Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Radiolabeled iodine isotope" most commonly refers to radioactive isotopes of iodine, such as Iodine-131 (I-131), used in nuclear medicine for diagnosis and treatment, primarily in thyroid disease (e.g., hyperthyroidism and thyroid cancer). I-131 is actively transported into thyroid cells via the sodium-iodide symporter, where its beta and gamma emissions can selectively destroy thyroid tissue or metastatic thyroid cancer due to the organ's natural iodine uptake [1][2][3][4][5][6][7]. "Radiolabeled iodine isotope" is not itself a receptor, enzyme, or typical therapeutic molecular target, but a radioactive molecule acting as a radiopharmaceutical agent or tracer.\n\n**Key clarifications:**\n- It is not a molecular target. It is a radiopharmaceutical agent, not a biological receptor, transporter, enzyme, or drug-binding macromolecule [2][3][4][7].\n- Best canonical form: For structured data, the canonical target should specify "Sodium-iodide symporter" for uptake, or "Thyroid tissue" as the physiological target, but not "radiolabeled iodine isotope" itself.\n- Common agents: Iodine-131 (I-131) is the radiolabeled iodine isotope most frequently used for therapy; Iodine-123 (I-123) and Iodine-125 (I-125) are used more for diagnosis or imaging [3][5][4].\n- If the query requires target information for a molecule that mediates the biological effects of radiolabeled iodine isotope, the preferred structured target would be "Sodium/iodide symporter (NIS)" or "Thyroid stimulating hormone receptor" in indirect contexts.\n\n**Summary:**\n"Radiolabeled iodine isotope" is not a canonical molecular target but a therapeutic/diagnostic agent. It is not appropriate as a biological target entry; instead, refer to the agent most often associated (e.g., Iodine-131), and list the appropriate protein or tissue it targets in biology (e.g., sodium-iodide symporter or thyroid gland). The query is best flagged as **is_incorrect: true** for use as a molecular target entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radiolabeled iodine isotope.